With a Trump-driven reduction of nearly 2,000 employees, agency officials view artificial intelligence as a way to speed ...

Dubbed Elsa, the tool was expected to roll out at the end of June. The FDA says it marks the dawn of a new era.

The agency has provided few details about its AI pilot as it makes moves on its “aggressive timeline” for rollout.

The agency has provided only limited details about its AI pilot as it advances an “aggressive timeline” for the tool's ...

The Food and Drug Administration has gone all in on AI since Martin Makary, M.D., took over the agency, most recently ...

The FDA has introduced ELSA, a groundbreaking AI tool designed to expedite the review process for drugs and medical devices.

Following a successful pilot, the Food and Drug Administration unveiled its in-house large language model designed to help ...

The Food and Drug Administration has officially launched "Elsa," a generative artificial intelligence platform designed to ...

The U.S. FDA announced this week that it deployed a generative AI tool called ELSA, now in use by staff across the agency, ...

The FDA is using Elsa to accelerate clinical protocol reviews, shorten the time needed for scientific evaluations and identify high-priority inspection targets.

Learn more about the generative AI technology that will be used at the Food and Drug Administration (FDA) to speed up reviews ...